[Abstract] We recently reported an Affinity-directed PROtein Missile (AdPROM) system for the targeted proteolysis of endogenous proteins of interest (POI) (Fulcher et al., 2016 and . AdPROM consists of the Von Hippel Lindau (VHL) protein, a Cullin 2 E3 ligase substrate receptor (Bosu and Kipreos, 2008) , conjugated to a high affinity polypeptide binder (such as a camelid nanobody) that recognises the target protein in cells. When introduced in cells, the target protein is recruited to the CUL2 E3 ubiquitin ligase complex for ubiquitin-mediated proteasomal degradation. For target protein recruitment, we have utilised both camelid-derived VHH domain nanobodies as well as synthetic polypeptide monobodies based on the human type III fibronectin domain (Sha et al., 2013; Fridy et al., 2014; Schmidt et al., 2016) . In this protocol, we describe detailed methodology involved in generating AdPROM constructs and their application in human cell lines for target protein destruction. AdPROM allows functional characterisation of the POI and its efficiency of target protein destruction overcomes many limitations of RNA-interference approaches, which necessitate long treatments and are associated with off-target effects, and CRISPR/Cas9 gene editing, which is not always feasible.
www.bio-protocol.org/e2614 
Primary antibody that recognises the POI
Note: We used in-house generated antibodies recognizing VPS34 and FAM83G in the first of the original entries (Fulcher et al., 2016 m. The following morning pick a single colony and inoculate 10 ml LB (50 µg/ml ampicillin) in a 50 ml Falcon tube and grow for 6-7 h at 37 °C, 220 rpm.
n. Add the entire contents to a 500 ml Erlenmeyer flask containing 150 ml LB (50 µg/ml ampicillin) and grow overnight at 37 °C, 220 rpm. 6. Place cells in the 37 °C incubator and incubate for 16 h.
Collect the medium from cells and dispose safely (by following appropriate disposal guidelines).
Replace with fresh complete medium and incubate cells for 24 h. www.bio-protocol.org/e2614
4. Prior to cell lysis, expression of the AdPROM and control constructs will need to be performed, and ideally a Tet/doxycycline induction time course performed to monitor both AdPROM expression and target protein degradation.
F. Degradation of proteins for which no nano/monobody is available
In the event that no nano/monobody exists for your POI, we have shown that it is possible to first introduce an endogenous GFP knockin tag onto the gene encoding the POI using CRISPR/Cas9 gene editing technology, to enable targeting of the GFP-tagged target protein with high affinity anti-GFP nanobodies.
Following successful GFP integration onto the target protein gene locus, the protocol for degradation of the GFP-tagged endogenous protein either constitutively or inducibly is the same as above (Procedure C-Procedure E). 
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